The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative: How Informatics Can Assist the Secondary Use of Electronic Health Records to Inform Regulatory Decisions
You must log in to view this content. All contents are accessible to AMIA members and meeting attendees. If you are interested in purchasing proceedings, please contact us at mail@amia.org